Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study.

Seong Young Kwon Myoung Hyoun Kim Eunjung Kong Ari Chong Su Woong Yoo Subin Jeon Soon-Ah Park Dae-Weung Kim Su Hwan Kang Jung Eun Choi Jung-Min Ha Shin Young Jeong Sang-Woo Lee

Published in: Clinical endocrinology (2021)

High-dose RAI (≥3.7 GBq) therapy significantly lowered the recurrence rate in patients with more than five metastatic LNs. Therefore, RAI dose should be determined based on the number of metastatic LNs as well as conventional risk factors.

Keyphrases

lymph node
squamous cell carcinoma
small cell lung cancer
high dose
risk factors
lymph node metastasis
low dose
magnetic resonance imaging
cross sectional
clinical trial
sentinel lymph node
mesenchymal stem cells
bone marrow
neoadjuvant chemotherapy
smoking cessation
double blind
rectal cancer